Year: 2012

MASON, OH, December 11, 2012 – AssureRx Health, Inc. today announced four key additions to its leadership team. The management appointments coincide with the need to support increasing GeneSightRx pharmacogenomic…

Personalized Medicine Company Expands Commercial Activities and Product Development in Neuropsychiatric Pharmacogenomics MASON, OH, May 30, 2012 – AssureRx Health, Inc. today announced the closing of a $12.5 million Series…

GeneSightRx® ADHD pharmacogenomic test is designed to support medication management of patients diagnosed with ADHD Mason, OH – May 7, 2012 – AssureRx Health, Inc. today announced it has launched…

Angel Capital Association Recognizes AssureRx Health For Leadership in Personalized Medicine for Behavioral Health Mason, OH – March 12, 2012 – The Angel Capital Association, a trade association of leading…

 Silicon Valley Bank Financing Follows Earlier Series B Equity Financing MASON, OH Jan. 31, 2012 – AssureRx Health, Inc., today announced that it has secured an $8 million Term and…

Pharmacogenomic testing now available in all 50 states MASON, OHIO Jan. 24, 2012 – AssureRx Health, Inc., announced today that its laboratory has been certified by the New York State…

 GeneSightRx 1.8 Features New Psychotropic Medications CINCINNATI, Jan. 17, 2012 – AssureRx Health, Inc., today announced the release of GeneSightRx 1.8, a pharmacogenomic testing program helping behavioral health clinicians select…